Read the receipt.
- Displayed amount
- Quote required Product-specific price unconfirmed
- Delivery route
- Injection
- Product status
- Provider-listed prescription
- Membership in this figure
- See provider inclusions and terms
- Quantity
- Confirm the exact supplied quantity
- Upfront commitment
- Confirm the initial charge and billing period
Confirm consultation, labs, shipping, supplies, cancellation and the complete initial invoice. Unspecified charges are not assumed to be zero.
Sources: Maximus — choosing a protocol, Maximus — growth hormone program
What this price means.
The growth-hormone page shows term-dependent program rates, but the exact medicine-specific quote remains unresolved. Ask which plan, pharmacy and supplied quantity apply before treating any program headline as this product’s price.
Sources: Maximus — choosing a protocol, Maximus — growth hormone program
The product context.
EGRIFTA WR is approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Its label specifically excludes weight-loss management and says long-term cardiovascular safety has not been established. A provider listing for tesamorelin does not establish that this approved brand is supplied. Compounded preparations do not inherit its approval.
Sources: EGRIFTA WR — prescribing information, FDA — compounding questions and answers
Before you pay.
What will actually be charged today?
Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.
Is this a clinical recommendation?
No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.
What should I compare it with?
Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.
Follow the evidence
Sources & price notes
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Maximus — choosing a protocol ↗
The official help article identifies sermorelin and tesamorelin. Product-specific quotations still require confirmation.
Checked October 9, 2026
- Maximus — growth hormone program ↗
Program-level prices vary by commitment. Do not assign the generic program price to every medication or intensity.
Checked October 9, 2026
- EGRIFTA WR — prescribing information ↗
Label defines the indication, limitations, contraindications and monitoring requirements. EGRIFTA WR is not indicated for weight-loss management.
Checked October 9, 2026
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
Checked October 8, 2026